Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults

Clinical trial NCT00383539 · COMPLETED

Trial details

NCT number: NCT00383539
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Orthomyxoviridae Infection Influenza Myxovirus Infection

Start date: 2006-09-01
Primary completion: 2007-07-01
Enrollment: 2256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.